|
RBM15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.504600E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93183999999125E-05 |
| Normal-vs-Stage2 |
3.742000E-01 |
| Normal-vs-Stage3 |
2.403400E-01 |
| Normal-vs-Stage4 |
7.033600E-01 |
| Stage1-vs-Stage2 |
6.773700E-02 |
| Stage1-vs-Stage3 |
1.539590E-02 |
| Stage1-vs-Stage4 |
1.582280E-03 |
| Stage2-vs-Stage3 |
9.755200E-01 |
| Stage2-vs-Stage4 |
5.923200E-01 |
| Stage3-vs-Stage4 |
5.129200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.315600E-03 |
| Normal-vs-AfricanAmerican |
1.246000E-01 |
| Normal-vs-Asian |
1.404050E-01 |
| Caucasian-vs-AfricanAmerican |
9.785000E-01 |
| Caucasian-vs-Asian |
8.090200E-02 |
| AfricanAmerican-vs-Asian |
1.261810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.973900E-02 |
| Normal-vs-Female |
2.33709999999387E-05 |
| Male-vs-Female |
2.360000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.660600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.118870E-03 |
| Normal-vs-Age(61-80Yrs) |
1.240220E-02 |
| Normal-vs-Age(81-100Yrs) |
4.713600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.298200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.962200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.593400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.126400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.022000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.497200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.194300E-02 |
| Normal-vs-Grade 2 |
7.75330000000185E-05 |
| Normal-vs-Grade 3 |
4.576000E-02 |
| Normal-vs-Grade 4 |
9.141200E-01 |
| Grade 1-vs-Grade 2 |
3.225000E-01 |
| Grade 1-vs-Grade 3 |
9.388400E-02 |
| Grade 1-vs-Grade 4 |
1.489660E-02 |
| Grade 2-vs-Grade 3 |
5.601800E-02 |
| Grade 2-vs-Grade 4 |
5.623600E-03 |
| Grade 3-vs-Grade 4 |
1.712050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.11830000043756E-07 |
| Normal-vs-ccB subtype |
4.892600E-01 |
| ccA subtype-vs-ccB subtype |
6.24590000000147E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.989580E-02 |
| Normal-vs-N1 |
8.127200E-01 |
| N0-vs-N1 |
5.599400E-01 |
|
|
